337 related articles for article (PubMed ID: 17940994)
1. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of the phosphorylation of signal transducers and activators of transcription in the outcome of interferon therapy for chronic hepatitis C.
Miyaaki H; Ichikawa T; Nakao K; Takeshita S; Shibata H; Ozawa E; Akiyama M; Miuma S; Eguchi K
Intervirology; 2008; 51(6):394-9. PubMed ID: 19258717
[TBL] [Abstract][Full Text] [Related]
3. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.
Larrea E; Aldabe R; Molano E; Fernandez-Rodriguez CM; Ametzazurra A; Civeira MP; Prieto J
Gut; 2006 Aug; 55(8):1188-96. PubMed ID: 16120756
[TBL] [Abstract][Full Text] [Related]
4. Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment.
Carrera G; Paternain JL; Carrere N; Folch J; Courtade-Saïdi M; Orfila C; Vinel JP; Alric L; Pipy B
Am J Gastroenterol; 2003 May; 98(5):1142-9. PubMed ID: 12809840
[TBL] [Abstract][Full Text] [Related]
5. Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs.
Melén K; Fagerlund R; Nyqvist M; Keskinen P; Julkunen I
J Med Virol; 2004 Aug; 73(4):536-47. PubMed ID: 15221897
[TBL] [Abstract][Full Text] [Related]
6. The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapy.
El-Saadany S; Ziada DH; El Bassat H; Farrag W; El-Serogy H; Eid M; Abdallah M; Ghazy M; Salem HA
Can J Gastroenterol; 2013 Feb; 27(2):e13-7. PubMed ID: 23472246
[TBL] [Abstract][Full Text] [Related]
7. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
[TBL] [Abstract][Full Text] [Related]
9. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to Interferon alpha.
Li J; Chen F; Zheng M; Zhu H; Zhao D; Liu W; Liu W; Chen Z
Antiviral Res; 2010 Mar; 85(3):463-9. PubMed ID: 19857525
[TBL] [Abstract][Full Text] [Related]
11. Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.
Kronenberger B; Rüster B; Elez R; Weber S; Piiper A; Lee JH; Roth WK; Zeuzem S
Hepatology; 2001 Jun; 33(6):1518-26. PubMed ID: 11391542
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression in chronic hepatitis C and the effect of interferon alpha treatment.
Manning DS; Sheehan KM; Byrne MF; Kay EW; Murray FE
J Gastroenterol Hepatol; 2007 Oct; 22(10):1633-7. PubMed ID: 17845691
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
15. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
16. ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment.
Chen L; Sun J; Meng L; Heathcote J; Edwards AM; McGilvray ID
J Gen Virol; 2010 Feb; 91(Pt 2):382-8. PubMed ID: 19846672
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.
Nelson DR; Marousis CG; Ohno T; Davis GL; Lau JY
Hepatology; 1998 Jul; 28(1):225-30. PubMed ID: 9657116
[TBL] [Abstract][Full Text] [Related]
18. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.
Wietzke-Braun P; Maouzi AB; Mänhardt LB; Bickeböller H; Ramadori G; Mihm S
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):991-7. PubMed ID: 16894313
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy.
Imanaka K; Tamura S; Fukui K; Ito N; Kiso S; Imai Y; Naka T; Kishimoto T; Kawata S; Shinomura Y;
J Viral Hepat; 2005 Mar; 12(2):130-8. PubMed ID: 15720527
[TBL] [Abstract][Full Text] [Related]
20. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
Naarendorp M; Kallemuchikkal U; Nuovo GJ; Gorevic PD
J Rheumatol; 2001 Nov; 28(11):2466-73. PubMed ID: 11708420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
